Comparison of transurethral columnar balloon dilatation of prostate vs. transurethral green laser photoselective vaporization of prostate in the treatment of benign prostatic hyperplasia
LI Xuechao1, WU Shikui1, ZHAN Yu1, DONG Jinkai1, MAI Haixing1, CHEN Lijun1
1 Department of Urology,the Fifth Medical Centre,Chinese PLA General Hospital,Beijing 100071,China
Abstract：Objective： To investigate the safety and clinical effect of the transurethral columnar balloon dilatation of prostate (TUCBDP) vs. the transurethral green laser photoselective vaporization of prostate (PVP) in the treatment of benign prostatic hyperplasia (BPH). Methods： From October 2017 to June 2018, TUCBDP and PVP were performed on 9 cases and 9 cases respectively. The indexes were compared, including age, course of disease, preoperative IPSS, the volume of prostate, operation time, hemoglobin reduction postoperation, catheter retention time postoperation, bladder irrigation time postoperation, hospital stays postoperation. Results： There was no significant difference in age, course of disease, IPSS of preoperation and the volume of prostate between the two groups (P>0.05). The intraoperative and postoperative indicators between the two groups were compared, and there was a significant difference in operative time between the TUCBDP group and the PVP group (P<0.05), the mean operative time in TUCBDP group was significantly shorter than that in PVP group. There were no statistically significant differences in hemoglobin reduction postoperation, catheter retention time postoperation, bladder irrigation time postoperation and hospital stays postoperation (P>0.05). Conclusion： TUCBDP and PVP are safe and effective for BPH. TUCBDP has shorter operation time, and this treatment has obvious advantages for elderly patients, patients complicated with other diseases and patients with poor surgical tolerance. But the long-term effect of TUCBDP remains to be seen.
李学超, 吴世奎, 詹钰, 董金凯, 麦海星, 陈立军. 经尿道柱状水囊扩开术与经尿道选择性绿激光汽化术治疗前列腺增生的比较[J]. 微创泌尿外科杂志, 2019, 8(4): 262-265.
LI Xuechao, WU Shikui, ZHAN Yu, DONG Jinkai, MAI Haixing, CHEN Lijun. Comparison of transurethral columnar balloon dilatation of prostate vs. transurethral green laser photoselective vaporization of prostate in the treatment of benign prostatic hyperplasia. JOURNAL OF MINIMALLY INVASIVE UROLOGY, 2019, 8(4): 262-265.
[1] 梁博,刘军,姜明东,等.经尿道棒状水囊前列腺扩开术治疗良性前列腺增生的临床疗效分析.中国现代医学杂志,2018,28(36):83-86. [2] 郭应禄. 经尿道柱状水囊前列腺扩开术.北京:北京大学医学出版社,2015: 75-79. [3] 冯杰,王成刚,赵勇斌,等.经尿道棒状水囊扩裂术在治疗良性前列腺增生中的运用及改进.当代医学,2019,25(9):160-162. [4] 那彦群,叶章群,孙颖浩,等.中国泌尿外科疾病诊断治疗诊治.北京:人民卫生出版社,2013:245. [5] PAWAN V, ANUP K, NIRAJ K, et al.Safety and efficacy of photoselective vaporization of prostate in patients receiving anticoagulants. Minerva Urol Nefrol, 2013,65(3):189-195. [6] PASCOE C, OW D, PERERA M, et al.Optimising patient outcomes with photoselective vaporization of the prostate (PVP): a review. Transl Androl Urol, 2017,6(2):S133-S141. [7] JIWRAJKA M, YAXLEY W, PERERA M, et al.Review and update of benign prostatic hyperplasia in general practice. Aust J Gen Pract, 2018,47(7):471-475. [8] 刁英智,任向宏,张明华,等.超声引导下经尿道前列腺水囊扩开术治疗良性前列腺增生的1年疗效分析.中华泌尿外科杂志,2014,35(6):457-460. [9] 张勇,张志超,田龙,等.复合球囊前列腺扩张术治疗前列腺增生的实验研究.现代泌尿外科杂志,2009,14(3):218-221. [10] HUANG WG, HUANG Z, XIAO GF, et al.Effect of transurethral split of the prostate using a double-columnar balloon catheter for benign prostatic hyperplasia: A single-center experience of 565 consecutive patients. Medicine (Baltimore), 2016,95(40):e4657. [11] ZHANG ZH, LUO F, SU YH, et al.Management of greenlight laser plus transurethral resection of prostate for elderly men. Medicine (Baltimore), 2018,97(33):e11862. [12] CHEN LJ, MAI HX, ZHAO L, et al.Experience of treating high risk prostate hyperplasia patients with a HPS120 laser. BMC Urol, 2013,13(5):64.
